HilleVax
HLVX
HLVX was delisted on the 16th of September, 2025.
76 hedge funds and large institutions have $88.7M invested in HilleVax in 2024 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 13 closing their positions.
113% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 15
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
21% more capital invested
Capital invested by funds: $73.5M → $88.7M (+$15.2M)
2.15% more ownership
Funds ownership: 83.85% → 86% (+2.2%)
4% less funds holding
Funds holding: 79 → 76 (-3)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$851K |
| 2 |
Morgan Stanley
New York
|
+$818K |
| 3 |
JP Morgan Chase
New York
|
+$363K |
| 4 |
Millennium Management
New York
|
+$289K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$249K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Braidwell
Stamford,
Connecticut
|
-$1.87M |
| 2 |
TC
Trium Capital
London,
United Kingdom
|
-$798K |
| 3 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$750K |
| 4 |
AC
Almitas Capital
Santa Monica,
California
|
-$470K |
| 5 |
CP
Catalys Pacific
Tokyo,
Japan
|
-$416K |
HLVX Hedge Fund Activity: Q4 2024 in Review
76 of the 7,608 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q4 2024, worth a combined $88.7M — up 21% from $73.5M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of HLVX and 10 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 32 added.
The largest buyer was Goldman Sachs, adding an estimated $851K. The largest seller was Braidwell, exiting entirely with an estimated $1.87M sold.
- 76 institutional investors held HilleVax (HLVX) as of Q4 2024, down from 79 in Q3 2024.
- Funds reported $88.7M of HilleVax stock for Q4 2024, up 21% quarter-over-quarter.
- 10 funds opened new HilleVax positions in Q4 2024 and 13 closed out, a net change of -3 holders.
- The largest HilleVax buyer in Q4 2024 was Goldman Sachs, an estimated $851K added.
- The largest HilleVax seller in Q4 2024 was Braidwell, an estimated $1.87M sold.
Based on aggregated 13F filings for Q4 2024.